Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature

Clin Liver Dis. 2019 Nov;23(4):737-754. doi: 10.1016/j.cld.2019.07.004. Epub 2019 Aug 31.

Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) is a well-established procedure used in the management of complications of portal hypertension. Although the most robust evidence supports the use of TIPS as salvage therapy in variceal hemorrhage, secondary prophylaxis of variceal bleeding, and treatment of refractory ascites, there is also data to suggest its efficacy in other indications such as hepatic hydrothorax, hepatorenal syndrome, and Budd-Chiari syndrome. Recent literature also suggests that TIPS may improve survival for certain subpopulations if placed early after variceal bleeding. This article provides an updated evidence-based review of the indications for TIPS. Outcomes, complications, and adequate patient selection are also discussed.

Keywords: Ascites; Esophageal varices; Portal hypertension; TIPS; Transjugular intrahepatic portosystemic shunt.

Publication types

  • Review

MeSH terms

  • Ascites / etiology
  • Ascites / therapy*
  • Budd-Chiari Syndrome / etiology
  • Budd-Chiari Syndrome / therapy
  • Esophageal and Gastric Varices / etiology
  • Esophageal and Gastric Varices / therapy*
  • Gastrointestinal Hemorrhage / etiology
  • Gastrointestinal Hemorrhage / prevention & control*
  • Gastrointestinal Hemorrhage / therapy
  • Hepatorenal Syndrome / etiology
  • Hepatorenal Syndrome / therapy
  • Humans
  • Hydrothorax / etiology
  • Hydrothorax / therapy
  • Hypertension, Portal / complications
  • Hypertension, Portal / therapy*
  • Patient Selection
  • Portasystemic Shunt, Transjugular Intrahepatic / methods*
  • Primary Prevention
  • Salvage Therapy
  • Secondary Prevention
  • Survival Rate